VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo.

Lee, C M

VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo. [electronic resource] - Oncogene Apr 2009 - 1694-705 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1476-5594

10.1038/onc.2009.12 doi


Animals
Basic Helix-Loop-Helix Transcription Factors--physiology
Cell Line
Female
Humans
Hypoxia-Inducible Factor 1, alpha Subunit--physiology
Kidney Neoplasms--etiology
Mice
Mice, Inbred C57BL
Mutation
Teratoma--blood supply
Von Hippel-Lindau Tumor Suppressor Protein--genetics